Get In Touch
  • According to Transparency Market Research’s latest report on the global endocrine testing market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of endocrine and metabolic disorders to escalate the growth of global endocrine testing market. Moreover, rising cases of diabetes are expected to fuel growth of the endocrine testing market
  • According to the report, the global endocrine testing market was valued at US$ 5.5 Bn in 2018 and is anticipated to expand at a CAGR of 6.4% from 2019 to 2027
fa global endocrine testing market

To know the scope of our report Get a Sample on Endocrine Testing Market?

Rise in Focus on Research & Development and Surge in Number of People with Diabetes Mellitus: Key Drivers of Global Endocrine Testing Market

  • Endocrine system is made up of endocrine glands that secrete hormones directly into the blood stream. Tests are performed to monitor levels of endocrine hormones (such as follicle stimulating hormone (FSH), Luteinizing Hormone (LH), estradiol, insulin and others) from biological samples. These tests aid in detection of deviation in the hormone production i.e. they help detect either hypersecretion (excess secretion) or hyposecretion (less secretion) that results in certain endocrine disorders such as infertility, menopause, thyroid dysfunction and others. Several disorders including different types of diabetes and PCOS have led to the rise in endocrine testing. For instance, according to an article published in Current Diabetes Reports, states that the prevalence of diabetes and PCOS has risen significantly. Thus, surge in number of people with endocrine and metabolic disorders is a key factor anticipated to drive the growth of endocrine testing market
  • Sedentary lifestyle and unhealthy diet are leading to surge in prevalence & incidence of diabetes. For instance, according to an article published in Diabetes Research and Clinical Practice, globally the prevalence of diabetes was 463 million in 2019 and is rising to 578 million by 2030. This is augmenting the demand for new testing methods with rapid results. To address these demands, the key players are investing in the research and development activities to develop and introduce products with new technologies, thereby boosting the growth of market.

Get a glimpse of the in-depth analysis through our Report Brochure

Rise in Geriatric Population Worldwide to Propel Global Endocrine Testing Market Growth

  • Constant rise in geriatric population across the globe directly impacts the growth of endocrine testing solutions and methodologies as this population is highly susceptible to several health disorders and creates a need for effective management of the diseases globally. Old age is one of the potential risks of developing hernia, thyroid disorders and other hormone imbalances.
  • Changes in endocrine system along with age include menopause in women, loss of skeletal mass, androgen deficiency in men, increased incidence of type 2 diabetes and decrease in growth hormone. Hence, endocrine glands and organs undergo a series of changes that ultimately affects the hormone levels in an aging individual, thus, rise in the global geriatric population is one of the major factors driving the endocrine testing market

High Cost of Technology to Hamper Global Endocrine Testing Market

  • High costs involved in research and development activities for understanding several cellular mechanisms stimulated by hormones and subsequent commercialization of the tests pose a challenging task for the endocrine testing manufacturers. This in turn results in high cost of monitoring and diagnosis of hormone secretion levels in the body. For instance, Roche developed lab automation systems in the year 2013 and invested around USD 11.6 billion for research and development activities in the financial year 2019. Also, Abbott Laboratories invested around 6% - 7% of their total revenue in research and development of the novel technologies and products. This results in high cost of the end product thereby leading to high cost of diagnostic technologies that negatively impacts the market growth.
  • Enhanced access to sophisticated technological platforms is the rationale behind successful development and introduction of effective endocrine testing solutions and methodologies. Hence, limited access to advanced diagnostic procedures deprive patients from availing quality diagnosis measures and decrease the patient outcomes. Thus, high cost of testing technology might hamper the growth of the endocrine testing market.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Endocrine Testing Market: Competitive Landscape

  • This report profiles major players in the global endocrine testing market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global endocrine testing market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global endocrine testing market are
    • Agilent Technologies,
    • F-Hoffmann La Roche Ltd
    • AB SCIEX,
    • Thermo Fisher Scientific
    • Abbott Laboratories
    • Bio-Rad Laboratories
    • DiaSorin S.p.A
    • Beckman Coulter Inc
    • Siemens Healthineers and bioMerieux

Global Endocrine Testing Market: Key Developments

Key players in the global endocrine testing market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global endocrine testing market. A few expansion strategies adopted by players operating in the global endocrine testing market are:

  • In May 2020, Roche acquired Stratos Genomics to further develop DNA based sequencing for diagnostic use
  • In March 2020, Thermo Fisher Scientific proposed to acquire QIAGEN N.V. as this acquisition would expand its specialty diagnostics portfolio with attractive molecular diagnostics capabilities, including infectious disease testing
  • In July 2019, Thermo Fisher Scientific announced a 3 year, US$4.5 million collaboration with Ontario Institute for Cancer Research (OICR) and Genome Canada and the to develop targeted next-generation sequencing-based assays and analysis software.

The report on the global endocrine testing market discussed individual strategies, followed by company profiles of manufacturers of endocrine testing products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global endocrine testing market.

TMR’s report on the global endocrine testing market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global endocrine testing market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global endocrine testing market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global endocrine testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global endocrine testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global endocrine testing market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global endocrine testing market.

The report delves into the competitive landscape of the global endocrine testing market. Key players operating in the global endocrine testing market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global endocrine testing market that have been profiled in this report.

Key Questions Answered in Global Endocrine Testing Market Report

  • What is the scope of growth for product companies in the global endocrine testing market?
  • What will be the Y-o-Y growth of the global endocrine testing market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global endocrine testing market?
  • Will North America continue to be the most profitable market for endocrine testing market?
  • Which factors are anticipated to hamper the growth of the global endocrine testing market during the forecast period?
  • Which are the leading key players in the global endocrine testing market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global endocrine testing market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global endocrine testing market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the endocrine testing market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the endocrine testing market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global endocrine testing market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global endocrine testing more reliably and accurately.

Regional Segmentation of Endocrine Testing Market 

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K. 
  • France
  • Italy 
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America 
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa 

 

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Global Endocrine Testing Market - Segmentation

Test Type

Estradiol (E2) Test

Follicle Stimulating Hormone (FSH) Test

Human Chorionic Gonadotropin (hCG) Test

Luteinizing Hormone (LH) Test

Dehydroepiandrosterone sulfate (DHEAS) Test

Progesterone Test

Testosterone Test

Thyroid Stimulating Hormone (TSH) Test

Prolactin Test

Cortisol Test

Insulin Test

Others (Gastrin, Thymosin, Secretin, etc.)

Diagnostic Technologies

Tandem Mass Spectrometry

Immunoassay technologies

Monoclonal and Polyclonal Antibody Technologies

Sensor Technologies

Clinical Chemistry Technologies

End-user

Commercial Laboratories

Ambulatory Care Centers

Home Based tests

Physician Offices

Region

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Endocrine testing Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Endocrine testing Market Analysis and Forecasts, 2017–2027

5. Key Insights

    5.1. Increasing prevalence and incidences of obesity and diabetes across globe

    5.2. Technological Advancements

    5.3. Key Developments 

6. Global Endocrine testing Market Analysis and Forecasts, by Test Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Endocrine testing Market Value Forecast By Test Type, 2017–2027

        6.3.1. Estradiol (E2) Test

        6.3.2. Follicle Stimulating Hormone (FSH) Test

        6.3.3. Human Chorionic Gonadotropin (hCG) Test 

        6.3.4. Luteinizing Hormone (LH) Test

        6.3.5. Dehydroepiandrosterone sulfate (DHEAS) Test

        6.3.6. Progesterone Test

        6.3.7. Testosterone Test 

        6.3.8. Thyroid Stimulating Hormone (TSH) Test

        6.3.9. Prolactin Test

        6.3.10. Cortisol Test

        6.3.11. Insulin Test

        6.3.12. Others (Gastrin, Thymosin, Secretin, etc.)

    6.4. Global Endocrine testing Market Attractiveness by Test Type

7. Global Endocrine testing Market Analysis and Forecasts, by Diagnostic Technologies

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Endocrine testing Market Value Forecast By Diagnostic Technologies, 2017–2027

        7.3.1. Tandem Mass Spectrometry

        7.3.2. Immunoassay technologies

        7.3.3. Monoclonal and Polyclonal Antibody Technologies

        7.3.4. Sensor Technologies

        7.3.5. Clinical Chemistry Technologies

        7.3.6. Others 

    7.4. Global Endocrine testing Market Attractiveness by Diagnostic Technologies

8. Global Endocrine testing Market Analysis and Forecasts, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Endocrine testing Market Value Forecast By End-user, 2017–2027

        8.3.1. Hospitals 

        8.3.2. Commercial Laboratories 

        8.3.3. Ambulatory Care Centers

        8.3.4. Home Based tests

        8.3.5. Physician Offices

    8.4. Global Endocrine testing Market Attractiveness by End-user

9. Global Endocrine testing Market Analysis and Forecasts, by Region

    9.1. Key Findings

    9.2. Global Endocrine testing Market Value Forecast by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Endocrine testing Market Attractiveness by Region

10. North America Endocrine testing Market Analysis and Forecast

    10.1.  Introduction

        10.1.1. Key Findings

    10.2. North America Endocrine testing Market Value Forecast by Test Type, 2017–2027

        10.2.1. Estradiol (E2) Test

        10.2.2. Follicle Stimulating Hormone (FSH) Test

        10.2.3. Human Chorionic Gonadotropin (hCG) Test 

        10.2.4. Luteinizing Hormone (LH) Test

        10.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test

        10.2.6. Progesterone Test

        10.2.7. Testosterone Test 

        10.2.8. Thyroid Stimulating Hormone (TSH) Test

        10.2.9. Prolactin Test

        10.2.10. Cortisol Test

        10.2.11. Insulin Test

        10.2.12. Others (Gastrin, Thymosin, Secretin, etc.)

    10.3.  North America Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027

        10.3.1. Tandem Mass Spectrometry

        10.3.2. Immunoassay technologies

        10.3.3. Monoclonal and Polyclonal Antibody Technologies

        10.3.4. Sensor Technologies

        10.3.5. Clinical Chemistry Technologies

        10.3.6. Others 

    10.4. North America Endocrine testing Market Value Forecast by End-user, 2017–2027

        10.4.1. Hospitals 

        10.4.2. Commercial Laboratories 

        10.4.3. Ambulatory Care Centers

        10.4.4. Home Based tests

        10.4.5. Physician Offices

    10.5.  North America Endocrine testing Market Value Forecast by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Endocrine testing Market Attractiveness Analysis 

        10.6.1. By Test Type

        10.6.2. By Diagnostic Technologies

        10.6.3. By End-user

        10.6.4. By Country/Sub-region

11. Europe Endocrine testing Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Endocrine testing Market Value Forecast by Test Type, 2017–2027

        11.2.1. Estradiol (E2) Test

        11.2.2. Follicle Stimulating Hormone (FSH) Test

        11.2.3. Human Chorionic Gonadotropin (hCG) Test 

        11.2.4. Luteinizing Hormone (LH) Test

        11.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test

        11.2.6. Progesterone Test

        11.2.7. Testosterone Test 

        11.2.8. Thyroid Stimulating Hormone (TSH) Test

        11.2.9. Prolactin Test

        11.2.10. Cortisol Test

        11.2.11. Insulin Test

        11.2.12. Others (Gastrin, Thymosin, Secretin, etc.)

    11.3.  Europe Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027

        11.3.1. Tandem Mass Spectrometry

        11.3.2. Immunoassay technologies

        11.3.3. Monoclonal and Polyclonal Antibody Technologies

        11.3.4. Sensor Technologies

        11.3.5. Clinical Chemistry Technologies

        11.3.6. Others 

    11.4. Europe Endocrine testing Market Value Forecast by End-user, 2017–2027

        11.4.1. Hospitals 

        11.4.2. Commercial Laboratories 

        11.4.3. Ambulatory Care Centers

        11.4.4. Home Based tests

        11.4.5. Physician Offices

    11.5.  Europe Endocrine testing Market Value Forecast by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. France

        11.5.3. U.K.

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Endocrine testing Market Attractiveness Analysis 

        11.6.1. By Test Type

        11.6.2. By Diagnostic Technologies

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Endocrine testing Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia -Pacific Endocrine testing Market Value Forecast by Test Type, 2017–2027

        12.2.1. Estradiol (E2) Test

        12.2.2. Follicle Stimulating Hormone (FSH) Test

        12.2.3. Human Chorionic Gonadotropin (hCG) Test 

        12.2.4. Luteinizing Hormone (LH) Test

        12.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test

        12.2.6. Progesterone Test

        12.2.7. Testosterone Test 

        12.2.8. Thyroid Stimulating Hormone (TSH) Test

        12.2.9. Prolactin Test

        12.2.10. Cortisol Test

        12.2.11. Insulin Test

        12.2.12. Others (Gastrin, Thymosin, Secretin, etc.)

    12.3.  Asia -Pacific Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027

        12.3.1. Tandem Mass Spectrometry

        12.3.2. Immunoassay technologies

        12.3.3. Monoclonal and Polyclonal Antibody Technologies

        12.3.4. Sensor Technologies

        12.3.5. Clinical Chemistry Technologies

        12.3.6. Others 

    12.4. Asia -Pacific Endocrine testing Market Value Forecast by End-user, 2017–2027

        12.4.1. Hospitals 

        12.4.2. Commercial Laboratories 

        12.4.3. Ambulatory Care Centers

        12.4.4. Home Based tests

        12.4.5. Physician Offices

    12.5.  Asia -Pacific Endocrine testing Market Value Forecast by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia -Pacific Endocrine testing Market Attractiveness Analysis 

        12.6.1. By Test Type

        12.6.2. By Diagnostic Technologies

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Endocrine testing Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Endocrine testing Market Value Forecast by Test Type, 2017–2027

        13.2.1. Estradiol (E2) Test

        13.2.2. Follicle Stimulating Hormone (FSH) Test

        13.2.3. Human Chorionic Gonadotropin (hCG) Test 

        13.2.4. Luteinizing Hormone (LH) Test

        13.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test

        13.2.6. Progesterone Test

        13.2.7. Testosterone Test 

        13.2.8. Thyroid Stimulating Hormone (TSH) Test

        13.2.9. Prolactin Test

        13.2.10. Cortisol Test

        13.2.11. Insulin Test

        13.2.12. Others (Gastrin, Thymosin, Secretin, etc.)

    13.3.  Latin America Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027

        13.3.1. Tandem Mass Spectrometry

        13.3.2. Immunoassay technologies

        13.3.3. Monoclonal and Polyclonal Antibody Technologies

        13.3.4. Sensor Technologies

        13.3.5. Clinical Chemistry Technologies

        13.3.6. Others 

    13.4. Latin America Endocrine testing Market Value Forecast by End-user, 2017–2027

        13.4.1. Hospitals 

        13.4.2. Commercial Laboratories 

        13.4.3. Ambulatory Care Centers

        13.4.4. Home Based tests

        13.4.5. Physician Offices

    13.5. Latin America Endocrine testing Market Value Forecast by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Endocrine testing Market Attractiveness Analysis 

        13.6.1. By Test Type

        13.6.2. By Diagnostic Technologies

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Endocrine testing Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Endocrine testing Market Value Forecast by Test Type, 2017–2027

        14.2.1. Estradiol (E2) Test

        14.2.2. Follicle Stimulating Hormone (FSH) Test

        14.2.3. Human Chorionic Gonadotropin (hCG) Test 

        14.2.4. Luteinizing Hormone (LH) Test

        14.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test

        14.2.6. Progesterone Test

        14.2.7. Testosterone Test 

        14.2.8. Thyroid Stimulating Hormone (TSH) Test

        14.2.9. Prolactin Test

        14.2.10. Cortisol Test

        14.2.11. Insulin Test

        14.2.12. Others (Gastrin, Thymosin, Secretin, etc.)

    14.3. Middle East & Africa Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027

        14.3.1. Tandem Mass Spectrometry

        14.3.2. Immunoassay technologies

        14.3.3. Monoclonal and Polyclonal Antibody Technologies

        14.3.4. Sensor Technologies

        14.3.5. Clinical Chemistry Technologies

        14.3.6. Others 

    14.4. Middle East & Africa Endocrine testing Market Value Forecast by End-user, 2017–2027

        14.4.1. Hospitals 

        14.4.2. Commercial Laboratories 

        14.4.3. Ambulatory Care Centers

        14.4.4. Home Based tests

        14.4.5. Physician Offices

    14.5. Middle East & Africa Endocrine testing Market Value Forecast by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Latin America Endocrine testing Market Attractiveness Analysis 

        14.6.1. By Test Type

        14.6.2. By Diagnostic Technologies

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis/Ranking by Company (2018)

    15.3. Company Profiles

        15.3.1. Abbott Laboratories

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Financial Overview 

            15.3.1.3. Growth Strategies

            15.3.1.4. SWOT Analysis. 

        15.3.2. Thermo Fisher Scientific Inc

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Financial Overview 

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis 

        15.3.3.   Beckman Coulter Inc

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Financial Overview 

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis 

        15.3.4.   Siemens Healthineers

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Financial Overview 

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5. bioMerieux SA

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Financial Overview 

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis 

        15.3.6. Bio-Rad Laboratories Inc

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Financial Overview 

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis 

        15.3.7. Agilent Technologies Inc

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Financial Overview 

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis 

        15.3.8. Sciex

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis 

        15.3.9  F-Hoffmann La Roche AG

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Financial Overview 

            15.3.9.3 Growth Strategies

            15.3.9.4 SWOT Analysis 

List of Table

Table 01: Global Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 02: Global Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017 2027

Table 03: Global Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 04: Global Endocrine Testing Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 07: North America Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 08: North America Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027

Table 09: North America Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 10: Europe Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 11: Europe Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 12: Europe Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027

Table 13: Europe Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 14: Asia-Pacific Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Asia-Pacific Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 08: Asia-Pacific Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027

Table 16: Asia-Pacific Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 17: Latin America Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18: Latin America Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 19: Latin America Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027

Table 20: Latin America Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 21: Middle East & Africa Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Middle East & Africa Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 23: Middle East & Africa Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027

Table 24: Middle East & Africa Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figure

Figure 01: Global Endocrine Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 02: Global Endocrine Testing Market Value Share, by Test Type, 2018 

Figure 03: Global Endocrine Testing Market Value Share, by Diagnostic Technologies, 2018

Figure 04: Global Endocrine Testing Market Value Share, by End-user, 2018

Figure 05: Global Endocrine Testing Market Value Share, by Region, 2019–2027

Figure 06: Global Endocrine Testing Market Value Share, by Test Type, 2018-2027

Figure 07: Global Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019-2027

Figure 07: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Estradiol (E2) Test

2019–2027

Figure 08: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Follicle Stimulating Hormone (FSH) Test, 2019–2027

Figure 09: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Human Chorionic Gonadotropin (hCG) Test, 2019–2027

Figure 10: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Luteinizing Hormone (LH) Test, 2019–2027

Figure 11: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Dehydroepiandrosterone sulfate (DHEAS) Test, 2019–2027

Figure 12: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Progesterone Test, 2019–2027

Figure 13: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Testosterone Test, 2019–2027

Figure 14: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Thyroid Stimulating Hormone (TSH) Test, 2019–2027

Figure 15: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Prolactin Test, 2019–2027

Figure 16: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Cortisol Test, 2019–2027

Figure 17: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Insulin Test, 2019–2027

Figure 18: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2019–2027

Figure 19: Global Endocrine Testing Market Value Share, Diagnostic Technologies, 2018-2027

Figure 20: Global Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019- 2027

Figure 21: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Tandem Mass Spectrometry, 2019–2027

Figure 22: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Immunoassay technologies, 2019–2027

Figure 23: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Monoclonal and Polyclonal Antibody Technologies, 2019–2027

Figure 24: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Sensor Technologies, 2019–2027

Figure 25: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Clinical Chemistry Technologies, 2019–2027

Figure 25: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2019–2027

Figure 26: Global Endocrine Testing Market Value Share, End-user, 2018-2027

Figure 27: Global Endocrine Testing Market Attractiveness Analysis, by End-user, 2019- 2027

Figure 28: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2019–2027

Figure 29: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Commercial Laboratories, 2019–2027

Figure 30: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Care Centers, 2019–2027

Figure 31: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Home Based tests, 2019–2027

Figure 32: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Physician Offices, 2019–2027

Figure 33: Global Endocrine Testing Market Value Share, by Region, 2018 and 2027

Figure 34: Global Endocrine Testing Market Attractiveness, by Region, 2019–2027

Figure 35: North America Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 36: North America Endocrine Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 37: North America Endocrine Testing Market Attractiveness Analysis, by Country, 2019 – 2027

Figure 38: North America Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 39: North America Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027

Figure 40: North America Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies,  2018 and 2027

Figure 41: North America Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027

Figure 42: North America Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 43: North America Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027

Figure 44: Europe Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 45: Europe Endocrine Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 46: Europe Endocrine Testing Market Attractiveness Analysis, by Country/Sub-region, 2019 – 2027

Figure 47: Europe America Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 48: Europe Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027

Figure 49: Europe Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies,  2018 and 2027

Figure 50: Europe Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027

Figure 51: Europe Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 52: Europe Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027

Figure 53: Asia-Pacific Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 54: Asia-Pacific Endocrine Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 55: Asia-Pacific Endocrine Testing Market Attractiveness Analysis, by Country/Sub-region, 2019 – 2027

Figure 56: Asia-Pacific America Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 57: Asia-Pacific Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027

Figure 58: Asia-Pacific Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies,  2018 and 2027

Figure 59: Asia-Pacific Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027

Figure 60: Asia-Pacific Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 61: Asia-Pacific Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027

Figure 62: Latin America Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 63: Latin America Endocrine Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 64: Latin America Endocrine Testing Market Attractiveness Analysis, by Country/Sub-region, 2019 – 2027

Figure 65: Latin America Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 66: Latin America Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027

Figure 67: Latin America Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies,  2018 and 2027

Figure 68: Latin America Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027

Figure 69: Latin America Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 70: Latin America Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027

Figure 71: Middle East & Africa Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 72: Middle East & Africa Endocrine Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 73: Middle East & Africa Endocrine Testing Market Attractiveness Analysis, by Country/Sub-region, 2019 – 2027

Figure 74: Middle East & Africa Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 75: Middle East & Africa Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027

Figure 76: Middle East & Africa Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies,  2018 and 2027

Figure 77: Middle East & Africa Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027

Figure 78: Middle East & Africa Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 79: Middle East & Africa Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027

Figure 80: Global Endocrine Testing Market Share, by Company, 2018

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Endocrine Testing Market